Skadden, Arps, Slate, Meagher & Flom LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Skadden, Arps, Slate, Meagher & Flom LLP‘s corporate offering covers both public and private M&A. Recent highlights for the office include advising Otsuka Pharmaceutical Co., Ltd. on its acquisition of Jnana Therapeutics Inc. Leading the team is Mitsuhiro Kamiya who is relied on for high-value domestic and international acquisitions, while Akira Kumaki also comes recommended for handling high-profile cross-border transactions. Louis Artime is another key name to note for his expertise in general corporate matters, including spin-offs, divestitures, and financings.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘They are a top-tier firm in this area. All lawyers with the firm are "elites" who are very reliable. Their responses are always speedy.’
- ‘Louis Artime and Mitsuhiro Kamiya are the best team to handle high-profile, cross-border transactions.’
Key clients
- Dai-ichi Life Holdings, Inc
- JX Nippon Mining & Metals Corporation
Work highlights
Advising Otsuka Holdings Co., Ltd. in the approximately US$1.12 billion acquisition by its subsidiary Otsuka Pharmaceutical Co., Ltd. of Jnana Therapeutics Inc.